Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

“Prior Authorization Assistance” May Be New Tool Under Medicare Rx

Executive Summary

Drug manufacturers may want to consider establishing prior authorization assistance programs to prepare for life under Medicare formularies, Parexel Health Policy & Payer Relations Senior Project Manager Tom Snyder said

You may also be interested in...



Formulary Balancing Act: Medicare Rules Weigh Access Versus Cost Control

The Medicare prescription drug benefit implementing regulations would require formularies to contain at least two drugs in every therapeutic class

Formulary Balancing Act: Medicare Rules Weigh Access Versus Cost Control

The Medicare prescription drug benefit implementing regulations would require formularies to contain at least two drugs in every therapeutic class

Medicare Rx Formulary Will Have More Than VA’s 30 Classes

The Medicare Part D model formulary will have more than the 30 therapeutic drug classes included in the Veterans Affairs formulary, Centers for Medicare & Medicaid Services Administrator Mark McClellan said at a National Health Council Medicare briefing in Washington, D.C. July 15

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS044399

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel